Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 358

1.

STAC3 incorporation into skeletal muscle triads occurs independent of the dihydropyridine receptor.

Campiglio M, Kaplan MM, Flucher BE.

J Cell Physiol. 2018 Dec;233(12):9045-9051. doi: 10.1002/jcp.26767. Epub 2018 Aug 2.

PMID:
30071129
2.

Calcium Influx and Release Cooperatively Regulate AChR Patterning and Motor Axon Outgrowth during Neuromuscular Junction Formation.

Kaplan MM, Sultana N, Benedetti A, Obermair GJ, Linde NF, Papadopoulos S, Dayal A, Grabner M, Flucher BE.

Cell Rep. 2018 Jun 26;23(13):3891-3904. doi: 10.1016/j.celrep.2018.05.085.

3.

The role of macrophage migration inhibitory factor in autoimmune liver disease.

Assis DN, Leng L, Du X, Zhang CK, Grieb G, Merk M, Garcia AB, McCrann C, Chapiro J, Meinhardt A, Mizue Y, Nikolic-Paterson DJ, Bernhagen J, Kaplan MM, Zhao H, Boyer JL, Bucala R.

Hepatology. 2014 Feb;59(2):580-91. doi: 10.1002/hep.26664. Epub 2013 Dec 20.

4.

Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis.

Leung J, Bonis PA, Kaplan MM.

Clin Gastroenterol Hepatol. 2011 Sep;9(9):776-80. doi: 10.1016/j.cgh.2011.05.010. Epub 2011 May 20.

PMID:
21699802
5.

Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

Bonder A, Retana A, Winston DM, Leung J, Kaplan MM.

Clin Gastroenterol Hepatol. 2011 Jul;9(7):609-12. doi: 10.1016/j.cgh.2011.03.019. Epub 2011 Apr 11.

PMID:
21440668
6.

Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.

Kaplan MM, Bonder A, Ruthazer R, Bonis PA.

Dig Dis Sci. 2010 Nov;55(11):3207-17. doi: 10.1007/s10620-010-1291-5. Epub 2010 Jun 18.

PMID:
20559727
7.

Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.

Kaplan MM, Bonis PA.

Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):239-41. doi: 10.1016/j.gcb.2010.03.013. Epub 2010 May 11. No abstract available.

8.

Risk of non-melanoma skin cancer in autoimmune hepatitis.

Leung J, Dowling L, Obadan I, Davis J, Bonis PA, Kaplan MM, Casey D, Viveiros K.

Dig Dis Sci. 2010 Nov;55(11):3218-23. doi: 10.1007/s10620-010-1145-1. Epub 2010 Feb 18.

PMID:
20165977
9.

Statins in primary biliary cirrhosis: are they safe?

Abu Rajab M, Kaplan MM.

Dig Dis Sci. 2010 Jul;55(7):2086-8. doi: 10.1007/s10620-009-0988-9. Epub 2009 Oct 1.

PMID:
19795210
10.

Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.

Kaplan MM, Poupon R.

Hepatology. 2009 Aug;50(2):652. doi: 10.1002/hep.22831. No abstract available.

PMID:
19309721
11.

Modafinil in the treatment of debilitating fatigue in primary biliary cirrhosis: a clinical experience.

Ian Gan S, de Jongh M, Kaplan MM.

Dig Dis Sci. 2009 Oct;54(10):2242-6. doi: 10.1007/s10620-008-0613-3. Epub 2008 Dec 12.

PMID:
19082890
12.

Quality of life and everyday activities in patients with primary biliary cirrhosis.

Selmi C, Gershwin ME, Lindor KD, Worman HJ, Gold EB, Watnik M, Utts J, Invernizzi P, Kaplan MM, Vierling JM, Bowlus CL, Silveira MG, Bossi I; USA PBC Epidemiology Group.

Hepatology. 2007 Dec;46(6):1836-43.

13.

Reversible hepatic decompensation in primary biliary cirrhosis due to hypercoagulability.

Lee HM, Amin M, Kaplan MM, Herlihy EF.

Ann Intern Med. 2007 Nov 6;147(9):675. No abstract available.

PMID:
17975196
14.

Pericentral liver cell necrosis associated with the use of high-dose intravenous methylprednisolone.

Lee HM, Ditelberg JS, Kaplan MM.

Dig Dis Sci. 2007 Jun;52(6):1533-4. Epub 2007 Apr 4. No abstract available.

PMID:
17406840
15.

Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature.

Retana AK, Kaplan MM, Erban JK.

Am J Gastroenterol. 2007 Jan;102(1):197-200. Epub 2006 Oct 13. Review.

PMID:
17037996
16.

Persistent cholestatic jaundice after ERCP.

Lee HM, Bonis PA, Kaplan MM.

Am J Gastroenterol. 2006 Jan;101(1):204-5. No abstract available.

PMID:
16405561
17.

Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.

Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM; USA PBC Epidemiology Group.

Hepatology. 2005 Nov;42(5):1194-202.

18.

Modafinil for the treatment of fatigue in primary biliary cirrhosis.

Kaplan MM, Bonis PA.

Ann Intern Med. 2005 Oct 4;143(7):546-7. No abstract available.

PMID:
16204174
19.

Steroid-responsive (autoimmune?) sclerosing cholangitis.

Sekhon JS, Chung RT, Epstein M, Kaplan MM.

Dig Dis Sci. 2005 Oct;50(10):1839-43. No abstract available.

PMID:
16187184
20.

Primary biliary cirrhosis.

Kaplan MM, Gershwin ME.

N Engl J Med. 2005 Sep 22;353(12):1261-73. Review. No abstract available. Erratum in: N Engl J Med. 2006 Jan 19;354(3):313.

PMID:
16177252

Supplemental Content

Loading ...
Support Center